EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

HIV-1 resistance mutations and genetic diversity among children failing antiretroviral treatment in five healthcare facilities in Benin, West Africa

Edwige Hermione Dagba Gbessin iD, Edmond Tchiakpe, René Kpemahouton Keke, Nicole Vidal, Michel Kiréopori Gomgnimbou, Haziz Sina, Euloge Senan Adjou, Aldric Afangnihoun, Moussa Bachabi, Akadiri Yessoufou, Abdoul-Salam Ouedraogo, Lamine Baba-Moussa iD

PLOS ONE · 2025

DOI: 10.1371/journal.pone.0317882 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2025. Verfasst von Edwige Hermione Dagba Gbessin und 11 weiteren Autor:innen. Beteiligte Einrichtung: NAZI BONI University, Bobo-Dioulasso, Burkina Faso. Hauptthemen laut MEDLINE: HIV-1, HIV Infections, Drug Resistance, Viral, Mutation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Antiretroviral treatment increases the risk of accumulation of resistance mutations that negatively impact the possibilities of future treatment. This study aimed to present the frequency of HIV-1 antiretroviral resistance mutations and the genetic diversity among children with virological failure in five pediatric care facilities in Benin.

Methods

A cross-sectional study was carried out from November 20, 2020, to November 30, 2022, in children under 15 years of age who failed ongoing antiretroviral treatment at five facilities care in Benin (VL > 3log 10 on two consecutive realizations three months apart). Viral loads were measured using the m2000 RealTime Abbott platform. Genotyping was carried out with the commercial Viroseq kit. Sequences were read on the ABI 3500 sequencer and then edited with ViroSeqHIVv3.0 software. The HIV drug resistance database at Stanford University was used to identify mutations and viral subtypes were assigned by phylogenetic analyses.

Results

The HIV-1 pol gene was sequenced in 47 participants with virological failure of antiretroviral treatment. The median age was 120 [Interquartile Range 90–144] months. The prevalent treatment was EFV base regimen (22/47; 46.8%). Median viral load was 4.39 log 10 [IQR 3.81–4.86 log 10 ] respectively. Resistance testing was successful among (37/47; 78.72%) children, resistance mutations were detected in (32/37; 86.48%) children, and (29/32; 90.62%) had at least one surveillance drug resistance mutation. Respectively (25/32; 78.12%), (28/32; 87.5%), (4/32; 12.90%), (22/32; 68.75%) had at least one resistance mutation associated with NRTIs, NNRTIs, PIs and NNRTIs+NRTIs. (12/32; 37.5%) of children carried mutations related to TAMs. the most frequently NRTIs identified were M184V (21/62; 33.9%) followed by TAMs (20/62; 32.2%) and T69G/D (2/62; 3.2%)s. Among mutations associated with NNRTIs K103N represented (18/64; 28.1%) followed by P225H (7/64; 10.9%). The I54V (3/6; 50%) mutation is the major PI observed. Genetic diversity is characterized by a preponderance of CRF02_AG (72%, 23/32), followed by unique recombinant forms (URFs) (25%, 8/32) and one subtype G.

Conclusion

A high rate of mutations has been observed in children. These data underline the importance of implementing routine genotypic testing in the biological monitoring of infected children to anticipate the accumulation of resistance mutations and thus compromise the treatment options available in Benin.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV-1HIV InfectionsDrug Resistance, ViralMutationGenetic VariationAnti-HIV AgentsHumansFemaleMaleChildBeninChild, PreschoolCross-Sectional StudiesInfantViral LoadAdolescentPhylogenyTreatment FailureHealth Facilities

Substanzen

Anti-HIV Agents

Autor:innen und Institutionen

  • NAZI BONI University, Bobo-Dioulasso, Burkina Faso.
  • National Reference Laboratory of Health Program Fighting Against AIDS in Benin (LNR/PSLS), Health Ministry, Akpakpa, Littoral, Benin.
  • Faculty of Sciences and Technology (FAST) and Institute of Applied Biomedical Sciences (ISBA), Department of Biochemistry and Cellular Biology, Laboratory of Cell Biology and Physiology, University of Abomey-Calavi, Abo…
  • UMI233 -TransVIHMI, Université de Montpellier, Institut National de la Santé et de la Recherche Médicale (INSERM), Institut de Recherche pour le Développement (IRD), Montpellier, France.
  • Higher Institute of Health Sciences (INSSA), Nazi Boni University, Bobo-Dioulasso. Molecular Biology Laboratory, Muraz Center, Bobo-Dioulasso, Burkina Faso.
  • Faculty of Sciences and Technology (FAST), Laboratory of Biology and Molecular Typing in Microbiology (LBTMM), University of Abomey-Calavi, Atlantic, Benin.

ORCID-Profile: Edwige Hermione Dagba Gbessin, Lamine Baba-Moussa

Zitieren

APA

Dagba Gbessin, E. H., Tchiakpe, E., Keke, R. K., Vidal, N., Gomgnimbou, M. K., Sina, H., Adjou, E. S., Afangnihoun, A., Bachabi, M., Yessoufou, A., Ouedraogo, A. S., & Baba-Moussa, L. (2025). HIV-1 resistance mutations and genetic diversity among children failing antiretroviral treatment in five healthcare facilities in Benin, West Africa. PLOS ONE. https://doi.org/10.1371/journal.pone.0317882

Vancouver

Dagba Gbessin EH, Tchiakpe E, Keke RK, Vidal N, Gomgnimbou MK, Sina H, et al. HIV-1 resistance mutations and genetic diversity among children failing antiretroviral treatment in five healthcare facilities in Benin, West Africa. PLOS ONE. 2025. doi:10.1371/journal.pone.0317882

BibTeX
@article{DagbaGbessin2025,
  author = {Dagba Gbessin, Edwige Hermione and Tchiakpe, Edmond and Keke, René Kpemahouton and Vidal, Nicole and Gomgnimbou, Michel Kiréopori and Sina, Haziz and Adjou, Euloge Senan and Afangnihoun, Aldric and Bachabi, Moussa and Yessoufou, Akadiri and Ouedraogo, Abdoul-Salam and Baba-Moussa, Lamine},
  title = {HIV-1 resistance mutations and genetic diversity among children failing antiretroviral treatment in five healthcare facilities in Benin, West Africa},
  journal = {PLOS ONE},
  year = {2025},
  doi = {10.1371/journal.pone.0317882}
}
Kostenlos starten →